Silver Book Fact

By mid-century, the number of people with Alzheimer’s disease is expected to grow to as many as 16 million, which is more than the current total population of New York City, Los Angeles, Chicago, and Huston combined.

Vernon, John, Robert Goldberg, Yashodhara Dash, and Guruprasaadh Muralimohan. Alzheimer’s Disease and Cost-effectiveness Analyses: Ensuring good value for money?. Working Paper — Pending Publication; 2007. http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=12477

Reference

Title
Alzheimer’s Disease and Cost-effectiveness Analyses: Ensuring good value for money?
Publisher
Working Paper — Pending Publication
Publication Date
2007
Authors
Vernon, John, Robert Goldberg, Yashodhara Dash, and Guruprasaadh Muralimohan
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Human Burden

Related Facts

  • In 2005, the total annual per person costs for patients with Parkinson’s disease was $23,101 in direct costs and $25,326 in indirect costs.  
  • Projected Numbers of People Aged 65 and Over in the U.S. Population with Alzheimer’s Disease (in Millions) Using the U.S. Census Bureau Estimates of Population Growth*  
  • In 2011, an estimated 5.4 million Americans have Alzheimer’s disease.  
  • Drug therapy for Parkinson’s disease costs more than $6 billion a year. Costs such as rehabilitation and home care can run as high as $150,000 per patient, per year.  
  • Average out-of-pocket spending over a five year period for those with dementia was $61,522 compared to $34,068 for those
    Average out-of-pocket spending over a five year period for those with dementia was $61,522 compared to $34,068 for those without dementia.